Crohn's disease, Lancet, vol.389, pp.1741-1755, 2017. ,
, Lancet, vol.389, pp.1756-1770, 2017.
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies, Lancet, vol.390, pp.2769-2778, 2018. ,
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders, J. Crohns Colitis, vol.11, pp.649-670, 2017. ,
Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-Based vs Trough Concentration-Based Dosing of Infliximab, Clin. Gastroenterol. Hepatol, vol.16, pp.1276-1283, 2018. ,
Effect of tight control management on Crohn's disease (CALM): A multicentre, randomised, vol.390, pp.2779-2789, 2018. ,
Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF? therapy: Results from the COIN study, Gut, vol.63, pp.72-79, 2012. ,
Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort, Inflamm. Bowel Dis, vol.21, pp.121-131, 2015. ,
TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD): Design and implementation of randomized clinical trial, Contemp. Clin. Trials, vol.42, pp.132-144, 2015. ,
The effects of inflammatory bowel disease on caregivers: Significant burden and loss of productivity, BMC Health Serv. Res, vol.20, 2020. ,
E-health in inflammatory bowel diseases: More challenges than opportunities? Dig. Liver Dis, vol.49, pp.1320-1326, 2017. ,
A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD), Am. J. Gastroenterol, vol.114, pp.472-482, 2019. ,
A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities, J. Crohns Colitis, 2020. ,
Compliance with the faecal calprotectin test in patients with inflammatory bowel disease. United Eur, Gastroenterol. J, vol.5, pp.702-707, 2017. ,
Is home monitoring of inflammatory bowel disease feasible? A randomized controlled study, Scand. J. Gastroenterol, vol.54, pp.849-854, 2019. ,
Integration of telemedicine into clinical practice for inflammatory bowel disease, Curr. Opin. Gastroenterol, vol.2020, pp.304-309 ,
E-health empowers patients with ulcerative colitis: A randomised controlled trial of the web-guided 'Constant-care' approach, Gut, vol.59, pp.1652-1661, 2010. ,
A Web-Based Telemanagement System for Improving Disease Activity and Quality of Life in Patients With Complex Inflammatory Bowel Disease: Pilot Randomized Controlled Trial, J. Med Internet Res, 2018. ,
Telemedicine for management of inflammatory bowel disease (myIBDcoach): A pragmatic, multicentre, randomised controlled trial, Lancet, vol.390, pp.959-968, 2017. ,
Cost-effectiveness of Telemedicine-directed Specialized vs Standard Care for Patients With Inflammatory Bowel Diseases in a Randomized Trial, Clin. Gastroenterol. Hepatol, vol.18, pp.1744-1752, 2020. ,
, IBDoc®Calprotectin Home Test Kit Procedure
, Step Instructions for the QuantOn Cal®App|QuantOn Cal®, p.28, 2020.
, , p.28, 2020.
, Calprotectin Home Test for Patient Self Testing of Their IBD Status; Calprotectin, p.28, 2020.
, , p.28, 2020.
Head-to-head comparison of three stool calprotectin tests for home use, PLoS ONE, vol.14, 2019. ,
A Noninferiority Randomized Clinical Trial of the Use of the Smartphone-Based Health Applications IBDsmart and IBDoc in the Care of Inflammatory Bowel Disease Patients, Inflamm. Bowel Dis, vol.26, pp.1098-1109, 2019. ,
Usability of a home-based test for the measurement of fecal calprotectin in asymptomatic IBD patients, vol.49, pp.991-996, 2017. ,
Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring, Intest. Res, vol.16, pp.546-553, 2018. ,
Point of care testing of fecal calprotectin as a substitute for routine laboratory analysis, Pract. Lab. Med, vol.10, pp.10-14, 2017. ,
Fecal Calprotectin Measured By Patients at Home Using Smartphones-A New Clinical Tool in Monitoring Patients with Inflammatory Bowel Disease, Inflamm. Bowel Dis, vol.22, pp.336-344, 2016. ,
Individualized home-monitoring of disease activity in adult patients with inflammatory bowel disease can be recommended in clinical practice: A randomized-clinical trial, World J. Gastroenterol, vol.25, pp.6158-6171, 2019. ,
Validation of a smartphone-based patient monitoring system measuring calprotectin as the therapy follow-up marker, J. Crohns Colitis, vol.1, pp.212-213, 2015. ,
, , p.23, 2020.
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications, J. Crohns Colitis, vol.13, pp.144-164, 2018. ,
Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools, Inflamm. Bowel Dis, vol.23, pp.1425-1433, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01595713
Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity, Clin. Gastroenterol. Hepatol, vol.15, pp.1742-1749, 2017. ,
COVID-19) Situation Reports, p.29, 2020. ,
International Organization for the Study of Inflammatory Bowel Disease Innovation in IBD Care During the COVID-19 Pandemic: Results of a Global Telemedicine Survey by the International Organization for the Study of Inflammatory Bowel Disease, Gastroenterology, 2020. ,
The day after COVID-19 in IBD: How to go back to 'normal', Nat. Rev. Gastroenterol. Hepatol, 2020. ,
The mHealth App Usability Questionnaire (MAUQ): Development and Validation Study, JMIR mHealth uHealth, vol.7, 2019. ,
, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2020 by the authors. Licensee MDPI